In breast cancer, a higher concentration of statins reduces the tube-forming ability of human endothelial cells in vitro by reducing the membrane localization of RhoA, subsequently suppressing VEGFR, FAK, and Akt protein expression [37]. This evidence concerns the gene RHOA and breast carcinoma.